The clinical management of acute intracerebral hemorrhage.

  title={The clinical management of acute intracerebral hemorrhage.},
  author={Venkatesh Aiyagari},
  journal={Expert review of neurotherapeutics},
  volume={15 12},
Intracerebral hemorrhage (ICH) is a stroke subtype with high mortality and significant disability among survivors. The management of ICH has been influenced by the results of several major trials completed in the last decade. It is now recognized that hematoma expansion is a major cause of morbidity and mortality. However, efforts to improve clinical outcome through mitigation of hematoma expansion have so far been unsuccessful. Acute blood pressure management has recently been shown to be safe… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.


Publications referenced by this paper.
Showing 1-10 of 97 references

Lancet Glob Health

Burden of Disease Study
2013;1(5):e259–81. • 2010
View 3 Excerpts
Highly Influenced

Antithrombotic Reversal Agents.

Hematology/oncology clinics of North America • 2017


AA Ginde, A Foianini, DM Renner

Idarucizumab for Dabigatran Reversal.

The New England journal of medicine • 2015

Similar Papers

Loading similar papers…